Edwards Lifesciences Corporation - Laporan Laba Rugi (TTM)

Edwards Lifesciences Corporation
CH ˙ BRSE ˙ US28176E1082
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Edwards Lifesciences Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 4,369 4,386 4,474 4,925 5,094 5,232 5,357 5,355 5,364 4,464 5,279 5,168 5,092 5,010 5,102 5,209 5,320 5,440 5,522 5,685
Change (%) 0.40 2.00 10.08 3.44 2.71 2.38 -0.04 0.16 -16.78 18.25 -2.11 -1.46 -1.61 1.84 2.10 2.13 2.24 1.52 2.95
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,070 1,081 1,109 1,205 1,236 1,249 1,255 1,190 1,130 722 1,018 987 985 978 1,026 1,064 1,076 1,118 1,132 1,201
Change (%) 0.94 2.62 8.67 2.55 1.07 0.47 -5.17 -5.00 -36.12 41.05 -3.10 -0.16 -0.70 4.90 3.67 1.16 3.83 1.32 6.09
% of Revenue 24.50 24.64 24.78 24.47 24.26 23.87 23.42 22.22 21.07 16.18 19.29 19.10 19.35 19.53 20.11 20.43 20.23 20.54 20.50 21.13
Gross Operating Profit 3,298 3,306 3,365 3,720 3,859 3,984 4,102 4,165 4,233 3,742 4,260 4,181 4,107 4,032 4,076 4,145 4,244 4,322 4,390 4,484
Change (%) 0.23 1.80 10.55 3.73 3.23 2.98 1.53 1.64 -11.61 13.86 -1.87 -1.77 -1.83 1.10 1.70 2.38 1.84 1.58 2.14
% of Revenue 75.50 75.36 75.22 75.53 75.74 76.13 76.58 77.78 78.93 83.82 80.71 80.90 80.65 80.47 79.89 79.57 79.77 79.46 79.50 78.87
SG&A 1,235 1,229 1,252 1,351 1,409 1,494 1,534 1,568 1,581 1,356 1,578 1,571 1,576 1,581 1,628 1,673 1,713 1,789 1,826 1,880
Change (%) -0.53 1.87 7.96 4.23 6.06 2.64 2.25 0.82 -14.19 16.34 -0.44 0.29 0.35 2.93 2.80 2.36 4.43 2.09 2.98
% of Revenue 28.28 28.01 27.98 27.44 27.65 28.55 28.63 29.28 29.47 30.39 29.90 30.41 30.95 31.56 31.90 32.12 32.19 32.88 33.06 33.08
R&D 759 761 780 824 866 903 925 950 946 844 951 944 953 963 985 1,013 1,024 1,053 1,051 1,055
Change (%) 0.24 2.58 5.54 5.16 4.28 2.39 2.76 -0.46 -10.81 12.78 -0.80 0.97 1.04 2.27 2.90 1.05 2.83 -0.20 0.42
% of Revenue 17.37 17.34 17.44 16.72 17.00 17.26 17.26 17.74 17.63 18.90 18.02 18.26 18.72 19.22 19.30 19.45 19.25 19.36 19.03 18.56
OpEx 3,065 3,070 3,141 3,380 3,510 3,646 3,713 3,708 3,657 2,922 3,585 3,678 3,690 3,523 3,602 3,575 3,659 3,959 3,990 4,096
Change (%) 0.18 2.31 7.61 3.86 3.87 1.84 -0.13 -1.38 -20.10 22.68 2.59 0.33 -4.54 2.25 -0.76 2.37 8.18 0.78 2.67
% of Revenue 70.15 69.99 70.20 68.62 68.90 69.68 69.31 69.25 68.18 65.46 67.91 71.17 72.47 70.31 70.59 68.62 68.78 72.78 72.25 72.05
Operating Income 1,304 1,316 1,333 1,545 1,584 1,586 1,644 1,647 1,707 1,542 1,694 1,490 1,402 1,487 1,500 1,634 1,661 1,481 1,533 1,589
Change (%) 0.94 1.29 15.91 2.52 0.15 3.63 0.17 3.63 -9.66 9.86 -12.06 -5.89 6.11 0.87 8.94 1.60 -10.84 3.51 3.67
% of Revenue 29.85 30.01 29.80 31.38 31.10 30.32 30.69 30.75 31.82 34.54 32.09 28.83 27.53 29.69 29.41 31.38 31.22 27.22 27.75 27.95
Interest Expense -21 -16 -16 -16 -17 -18 -18 -18 -17 -19 -19 -19 -19 -18 -18 -18 -18 -20 -20 -20
Change (%) -23.67 -0.00 4.43 4.85 6.36 -0.00 -3.80 -4.52 13.61 -0.00 -0.00 -0.00 -8.33 -0.00 -0.00 -0.00 12.50 -0.00 -0.00
% of Revenue -0.47 -0.36 -0.35 -0.34 -0.34 -0.35 -0.34 -0.33 -0.32 -0.43 -0.36 -0.37 -0.38 -0.35 -0.34 -0.34 -0.33 -0.36 -0.36 -0.35
Net Income 794 823 851 1,462 1,477 1,503 1,538 1,455 1,459 1,522 1,489 1,390 1,431 1,402 1,414 1,473 4,159 4,175 4,181 4,148
Change (%) 3.69 3.35 71.84 1.02 1.75 2.36 -5.40 0.23 4.33 -2.17 -6.67 2.98 -1.99 0.81 4.19 182.34 0.38 0.15 -0.79
% of Revenue 18.18 18.77 19.02 29.69 29.00 28.73 28.72 27.18 27.20 34.09 28.20 26.89 28.10 27.99 27.71 28.28 78.17 76.75 75.71 72.96

Source: Capital IQ

Other Listings
MX:EW
IT:1EW € 70.88
DE:EWL € 69.12
US:EW US$ 80.94
AT:EWLS
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista